Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Obesity

A novel anti-obesity peptide that targets the hypothalamus

Nature Reviews Endocrinology volume 21, page 267 (2025)Cite this article

Subjects

Access through your institution
Buy or subscribe

Computational tools that predict which amino acid sequences are produced by cleavage enzymes can accelerate the discovery of bioactive peptides with therapeutic potential. A study recently published in Nature presents a peptide prediction programme that was used to search for novel anti-obesity peptides made by prohormone convertase enzymes (also known as proprotein convertase subtilisin/kexin (PCSK) enzymes).

After using their programme to predict the amino acid sequences of putative peptide products of PCSK enzyme activity, the team created a library containing 100 predicted peptides that had no known function. Next, they tested which of these peptides might be able to influence neuronal signalling and pancreatic β-cell activity to regulate metabolism. They treated cells from a rat phaeochromocytoma cell line and cells from a rat β-cell line with the peptides, then measured changes in Fos mRNA transcription. BRP, which is a predicted product of PCSK cleavage of the protein BRINP2, elicited a notable increase in Fos expression in both of the cell lines. To confirm whether BRP is produced in humans and in mice, the researchers performed liquid chromatography–mass spectrometry on samples of cerebrospinal fluid from human donors and mouse brain tissue. Their results showed that BRP was present in both sample types. They also tested whether PCSK1 produces BRP in vivo by measuring brain levels of BRP in wild-type mice and in transgenic mice in which PCSK1 function is impaired. They found that the levels of BRP were considerably reduced in the brains of the transgenic mice, which suggests that PCSK1 activity contributes to BRP production.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

Original article

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Endocrinology http://www.nature.com/nrendo/

    Senegal Carty

Authors
  1. Senegal Carty
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Senegal Carty.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carty, S. A novel anti-obesity peptide that targets the hypothalamus. Nat Rev Endocrinol 21, 267 (2025). https://doi.org/10.1038/s41574-025-01104-0

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41574-025-01104-0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing